REVENUES

9 Months Ended

Sep. 30, 2024

Revenue from Contract with Customer [Abstract]

REVENUES

NOTE 6 – REVENUES:

Disaggregation of revenue

	Nine months ended				Three months ended
	September 30,				September 30,
	2024		2023		2024		2023
	USD in thousands				USD in thousands
Development Services (*)		843		317		548		105
Products		1,817		770		744		5
Total Revenues		2,660		1,087		1,292		110

(*) During the second quarter of 2022, the Company completed the development of a customer-specific project for a Fortune 500 multinational healthcare corporation and moved from the development phase of the project to its production phase. As a result, during the nine months ended September 30, 2024, the Company recognized development services revenues in the amount of $317 thousand and related development costs previously deferred in the amount of $180 thousand. The amounts were recognized based on the expected manufacturing term of the product, which the Company estimates at seven years.   In addition, the Company recognized product revenues of $1,731 thousand during the nine months ended September 2024 from the sale of units of the product developed in the context of these development services.   During the nine months ended September 30, 2024 the Company recognized development services revenues in the amount of $526 thousand from development and customization contracts in which the performance obligation is satisfied over time.

Contract fulfillment assets and Contract liabilities:

The Company’s contract fulfillment assets and contract liabilities as of September 30, 2024, and December 31, 2023, were as follows:

	September 30,		December 31,
	2024		2023
	USD in thousands
Contract fulfillment assets		1,123		1,256
Contract liabilities		2,094		2,322

Contract liabilities include deferred service and advance payments.

The change in contract fulfillment assets:

	September 30,			December 31,
	2024			2023
	USD in thousands
Balance at beginning of the period		1,256			1,495
Contract costs deferred during the period		47
Contract costs recognized during the period		(180	)		(239	)
Balance at end of the period		1,123			1,256

The change in contract liabilities:

	September 30,			December 31,
	2024			2023
	USD in thousands
Balance at beginning of the period		2,322			3,644
Revenue deferred during the period		161			-
Revenue recognized during the period		(389	)		(1,322	)
Balance at end of the period		2,094			2,322

Remaining Performance Obligations

Remaining Performance Obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that are expected to be invoiced and recognized as revenue in future periods. As of September 30, 2024, the total RPO amounted to approximately $16.0 million. The total RPO amount includes an amount exceeding $10 million related to a long-term purchase order agreement signed in Q3.2024 with a leading international defense contractor, in respect of which no deferred revenue was recorded and no fulfillment of performance obligations commenced as of September 30, 2024.

ODYSIGHT.AI INC. (Formerly known as ScoutCam Inc.)

NOTES TO THE INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS